Islamorada Distilling
ISLAMORADA BEVERAGES, ISLAMORADA DISTILLING LLC — ISLAMORADA, FL
Florida
About Islamorada Distilling
Islamorada Distilling is a vodka producer based in Florida. According to the Alcohol and Tobacco Tax and Trade Bureau's Cola registry, the brand holds one approved label registration on record, with the most recent approval documented in 2022. The distillery's vodka offering is classified in the 80 to 89 proof category, a standard range for vodka spirits. The brand maintains a single product group within the vodka category as listed on spirits retail platforms. As a Florida-based distillery, Islamorada Distilling represents the state's participation in the broader American spirits market. The company's presence in the TTB registry reflects its compliance with federal labeling and production standards required for spirits distribution and sale in the United States.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
 | Islamorada Distilling VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2022-06-21 | ISLAMORADA BEVERAGES, ISLAMORADA DISTILLING LLC |
Page 1 of 1
Islamorada Distilling at a Glance
Islamorada Distilling has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2022-06-21 and 2022-06-21. Produced in Florida.
All information sourced from public TTB records.
Are you the owner or distributor of Islamorada Distilling?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
Islamorada Beverages, Islamorada Distilling LLCRelated Brands
- Muscle also from Florida
- Three Olives also from Florida
- Florida Cane also from Florida
- Ice Pik also from Florida
- Dark Door Spirits also from Florida
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Svedka also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
- A.M. Scott Distillery also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.